Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > HOW LONG IS THIS GOING TO TAKE
View:
Post by frewil11 on Dec 21, 2020 10:30am

HOW LONG IS THIS GOING TO TAKE

  • Validation of Aristotle as a Lab Developed Test (“LDT”) is underway.
Comment by Skrit37 on Dec 21, 2020 10:43am
Less then 2 months
Comment by Skrit37 on Dec 21, 2020 11:01am
I forgot to add In the Q2 CC..at approx 30min mark he says what I posted above
Comment by LithLover on Dec 21, 2020 10:54am
In the June prospectus it reads: The Company intends to publish data about Aristotle® , prepare CAP and CLIA clinical validation, and subsequently prepare for commercial launch of the product across the United States. The Company intends to eventually launch this product into Canada and the European Union and then more broadly thereafter subject to obtaining the relevant regulatory approvals ...more  
Comment by Newfinvest on Dec 21, 2020 11:50am
This post has been removed in accordance with Community Policy
Comment by Melray on Dec 21, 2020 2:22pm
https://www.oraldna.com/trends-in-salivary-testing/index.php/2018/03/09/definition-clia-certified-cap-accredited-what-does-this-mean/
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities